Impact and prognosis of the expression of IFN-α among tuberculosis patients
Open Access
- 15 July 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (7) , e0235488
Abstract
Mycobacterium tuberculosis (M.tb) infection stimulates the release of cytokines, including interferons (IFNs). IFNs are initiators, regulators, and effectors of innate and adaptive immunity. Accordingly, the expression levels of Type I (α, β) and II (γ) IFNs, among untreated tuberculosis (TB) patients and household contacts (HHC) clinically free of TB was assessed. A total of 264 individuals (TB patients-123; HHC-86; laboratory volunteers-55; Treated TB patients-36) were enrolled for this study. IFN-α mRNA expression levels predominated compared to IFN-γ and IFN-β among untreated TB patients. IFN-α transcripts were ~3.5 folds higher in TB patients compared to HHC, (pppIn-vitro, IFN-α failed to restrict the replication of intracellular M.tb. The anti-mycobacterial activity of IFN-γ was compromised in the presence of IFN-α, but not by IFN-β. The expression of IFN-α and β diminished or is absent, among successfully treated TB patients. These observations suggest the utility of assessment of Type I IFNs expression levels as a prognostic marker to monitor tuberculosis patient response to chemotherapy because changes in Type I IFNs expression are expected to precede the clearance and /reduction in bacterial load.Keywords
Funding Information
- Indian Council of Medical Research (project ID : 2013-0063)
This publication has 49 references indexed in Scilit:
- Genome-Wide Expression Profiling Identifies Type 1 Interferon Response Pathways in Active TuberculosisPLOS ONE, 2012
- Mycobacterium Tuberculosis Activates the DNA-Dependent Cytosolic Surveillance Pathway within MacrophagesCell Host & Microbe, 2012
- Prevalence, Distribution and Functional Significance of the −237C to T Polymorphism in the IL-12Rβ2 Promoter in Indian Tuberculosis PatientsPLOS ONE, 2012
- Activation of Interferon Regulatory Factor 5 by Site Specific PhosphorylationPLOS ONE, 2012
- Type I interferon: friend or foe?Journal of Experimental Medicine, 2010
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γJournal of Experimental Medicine, 2010
- IFN-β improves BCG immunogenicity by acting on DC maturationJournal of Leukocyte Biology, 2008
- Modulation of Gamma Interferon Receptor 1 byMycobacterium tuberculosis: a Potential Immune Response Evasive MechanismInfection and Immunity, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001